样式: 排序: IF: - GO 导出 标记为已读
-
Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-13 Shelby Reid PharmD, Robert Nichols PharmD, Stevie Veach PharmD, Eilan Alhersh MSc, Matthew Witry PharmD PhD
Depression is a significant source of morbidity but often goes undiagnosed. Broader screening is recommended, and pharmacists could contribute. Assess the feasibility of community pharmacy depression and anxiety screening and describe the medication-related problems (MRP) identified, pharmacist interventions, and provider responses for high-risk patients. This pilot was conducted between October 2022
-
-
Unleashing the power of science and research to advance pharmacy J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-13 Spencer E. Harpe
-
By your powers combined...We are the APhA Academy of Pharmacy Practice and Management! J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-13 Patricia H. Fabel
-
The vital role of peer reviewers J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-13 Pamela C. Heaton BSPharm PhD FAPhA
-
Earth Day: An opportunity for pharmacists to act J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-13 Kimberly M. Kelly PhD MS FSBM, Hayley Blackburn PharmD, Michelle Fravel PharmD, Alice Gahbauer PharmD, Karl Maier PhD, Jean C. Bikomeye MPH
-
Towards inclusive healthcare: Pharmacists’ perceptions on academic preparedness and healthcare provision for the LGBTQIA+ community J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-06 Vinicius Lima Faustino, Marília Berlofa Visacri PhD, Patricia Melo Aguiar PhD
-
Effect of Pregabalin Initiation on Diuretic Requirements in Patients with Chronic Heart Failure J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-02 Avital Basri PharmD, Meredith A. Sigler PharmD BCPS, Kevin C. Kelly PharmD BCPS, Dawn Lopez PharmD CDCES, Carlos Alvarez PharmD MSc MSCS BCPS
Literature on pregabalin use in patients with heart failure is largely limited to patient case reports and cohort studies. To evaluate the effect of pregabalin initiation on diuretic requirements in patients with heart failure. A retrospective analysis of patients with heart failure who were started on pregabalin between January 1, 2014 and September 1, 2021 at the Veterans Affairs North Texas Health
-
Impact of Automated Dispensing Solutions in Long-Term Care Facilities and Closed-Door Pharmacies: A Mixed Methods Study of Medication Management J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-02 Alex Black PharmD MBA, Dennis Tribble PharmD FASHP, Jacie Strumpf, Stacey Fitzgibbons RN CCRP, Doina Dumitru PharmD MBA FASHP, Julia Lucaci PharmD MS, Molly Jung Ph.D. MPH, Amar Ramudhin PhD
Financial, operational, and clinical workflow impacts of deploying an automated dispensing cabinet (ADC) in long-term care (LTC) facilities based on actual observations have not been documented in peer-reviewed literature. To evaluate the impact of a closed-door pharmacy (CDP) implementing an ADC with unique secure, removable, and transportable locked pockets in an unstudied setting (LTC facilities)
-
Pharmacists’ Role in Maternal Immunization J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-01 Kyle J. Gomes BSc, Parkash Ragsdale BSc (Biochem) BSc (Pharm), Dr. Nirma Khatri Vadlamudi PhD MPH
-
SOCIODEMOGRAPHIC INEQUITIES IN COVID-19 VACCINATION AMONG ADULTS IN THE UNITED STATES, 2022 J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-01 J, e, n, n, y, , S, ., , G, u, a, d, a, m, u, z, , M, S, P, H, , P, h, D
Despite the availability of COVID-19 vaccines since December 2020, sociodemographic inequities in vaccination and preventable COVID-related deaths persist. To inform efforts for equitable COVID-19 vaccination campaigns, a comprehensive national evaluation of existing inequities is necessary. To examine sociodemographic inequities in COVID-19 vaccination receipt using data from the 2022 National Health
-
Pharmacist Assessments and Care to Improve Adult Vaccination Rates: A Report from Project IMPACT Vaccine Confidence J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-01 Benjamin M. Bluml RPh, Scott A. Hamstra MD FAAP ABP, Lisa L. Tonrey MHA RPh PhC FAPhA, Jonathan B. Little PharmD, Aaron J. Bonham MSc, John D. Grabenstein RPh PhD FAPhA
Neglect of vaccination needs among adults results in a needless burden of hospitalization, suffering, and death. America's community pharmacists deliver a substantial portion of adult vaccinations, yet many Americans still have unmet vaccination needs. This study evaluated rates of vaccine contraindications, acceptance, and willingness to be vaccinated among ambulatory adults. This was a prospective
-
Patients’ Willingness to Pay for Naloxone: A National Cross-Sectional Survey of Prescription Opioid Users with Chronic Pain in the US J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-03-01 Yinan Huang M.S Ph.D., Toby M. Coggins BS, Sarah Cirildo BS, Chandler Gandy BS, Rajender R. Aparasu PhD FAPhA, J. Douglas Thornton Ph.D. PharmD BCPS
Millions of US people have been heavily affected by opioids. In March 2023, the FDA approved naloxone as an OTC medication. This has allowed more access to patients at high risk of opioid overdose. However, the patient's willingness to pay for naloxone at the pharmacy counter has not been assessed. To characterize factors associated with the willingness to pay for naloxone among the patient group.
-
Retraining transplant pharmacy staff to reduce Medicare Part B prescription billing errors post-transplant J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-28 Kirsten Mitchell, Sarah Osman, Carey Vallone, Michael Wilson, Chelsea Ray, Keren Rodriguez, Chris Hayes, Genny Staff, Rachel Chelewski, Katie R. Cruchelow, Autumn D. Zuckerman
Medicare Part B (MedB) imposes penalties for certain errors in prescription billing of post-transplant medications, which can greatly affect pharmacy revenue. To prevent MedB billing fines, pharmacy staff must be cognizant of specific MedB requirements. This quality improvement project aimed to retrain certified pharmacy technicians (CPhTs) on common billing errors and evaluate changes in error rates
-
Effect of Pharmacist Interventions on the Management of Overweight and Obesity: A Systematic Review J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-27 Ibrahim S. Alhomoud, Emily Cook, Dhruv Patel, Roy Brown, Dave L. Dixon
Pharmacists are underused healthcare professionals who are well positioned to provide weight management interventions; however, a systematic review of the literature supporting the role of pharmacists in weight management is lacking. To conduct a systematic review to assess the body of evidence supporting the role of pharmacists in the management of obesity. A literature search of OVID MEDLINE, Embase
-
State health departments leverage pharmacy partnerships across the nation to advance diabetes care initiatives. J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-26 Robert Montierth, Melissa Bing, Debra Sanchez-Torres, Poonam Mahajan, Justin Alexander, Margaret (Jean) Gearing
In 2018, the Centers for Disease Control and Prevention (CDC)’s Division of Diabetes Translation (DDT) initiated a five-year cooperative agreement funding opportunity with departments of health in every state and the District of Columbia. The funded recipients pursued activities that strengthened diabetes management and type 2 diabetes prevention interventions within their jurisdictions. An option
-
Enhancing availability of services to control hypertension through a team-based care approach that includes pharmacists J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-23 Cidney C. Wilson, Nicole L. Therrien, Kara E. MacLeod, Cindy Soloe, Mihaela Johnson, Mark D. Rivera, Julia Jordan, Sharada Shantharam, Jasmin Minaya-Junca, Erika B. Fulmer, Hae Mi Choe
Primary care physician (PCP) shortages are expected to increase. The Michigan Medicine Hypertension Pharmacists’ Program uses a team-based care (TBC) approach to redistribute some patient care responsibilities from PCPs to pharmacists for patients with diagnosed hypertension. This evaluation analyzed whether the Michigan Medicine Hypertension Pharmacists’ Program increased the availability of hypertension
-
Development and implementation of an in-hospital pharmacist emergency response simulation training curriculum J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-23 Kaylee Marino, Kaitlin E. Crowley, Lydia Ware, Kenneth Lupi, Afaf Sulaiman Alblooshi, Faten Abdullah Alradini, Andrew Eyre
Medical simulation is an effective educational tool used to increase confidence, improve knowledge, and refine skills when responding to high-acuity situations. Despite established roles of the pharmacist on the hospital code team, most institutions lack formalized pharmacist training for code team responses. This pre-post analysis aimed to evaluate the impact of a didactic and simulation-based code
-
Stakeholder perspectives on electronic prescribing in primary care: A scoping review J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-23 Farzan Bolouki Yazdi, Frances Barraclough, Jack Charles Collins, Jenny Chen, Sarira El-Den
Electronic prescribing (e-prescribing) provides a convenient, efficient, paperless mechanism for the legal transfer of prescriptions between service users, prescribers, and dispensers. There have been advances in e-prescribing processes and increased uptake of e-prescribing globally, in recent years. To explore stakeholder perspectives on e-prescribing in primary care settings. A scoping review was
-
Spatial accessibility and travel to pharmacy by type in the Detroit region J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-23 Xiaomeng Li, Igor Vojnovic, Arika Ligmann-Zielinska
Community pharmacies are a critical part of the health care provision system. Yet less is understood about the spatial accessibility to pharmacies and how people travel to reach these services. This study compared spatial accessibility and actual travel to different types of pharmacies among selected neighborhoods in the Detroit region. Three types of neighborhoods were selected and compared, including
-
Associated factors to non-medical and medical use of psychoactive medication among Mexican adolescents and adults in a national household survey J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-23 Copytzy Cruz-Cruz, Marycarmen Bustos-Gamiño, Jorge Villatoro-Velázquez, Rosie Mae Henson, Francisco-Javier Prado-Galbarro, Carlos Sanchez-Piedra, Lorena López-Pérez, María de Lourdes Gutiérrez-López, Nancy Amador-Buenabad, Claudia Iveth Astudillo-García
Non-medical use of psychoactive medication is a public health problem. Studies in other contexts indicate that individual sociodemographic characteristics are associated with non-medical use, but these associations have not been assessed in the Mexican context. To estimate the prevalence non-medical and medical use of psychoactive medication among Mexican adolescents and adults’ medication users and
-
An assessment of a sleep aid and sleep promotion practices in hospitalized medical Patients J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-19 Marisa C. Rinehart, Sona Ghorashi, Mojdeh S. Heavner, Asha Tata, Matthew Bathula, Sean Kelly, Siu Yan A Yeung, Kaitlin Landolf, Jennifer Y. So, Nidhi Goel, Brian E. Grover
Half of patients admitted to medicine units report sleep disruption, which increases the risk of sleep deprivation. Non-pharmacological interventions are the first step to improving sleep. However, utilization of sleep aids continues to be prevalent. Limited data are available on sleep aid prescribing practices across transitions of care. The aim of this study was to describe the current practices
-
Impact of altered mental status on antibiotic prescribing and outcomes in hospitalized patients presenting with pyuria J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-18 Haley N. Boerckel, Lacy J. Worden, Lisa A. Salvati, Andrew P. Jameson, Lisa E. Dumkow
Pyuria is nonspecific and may result in over-treatment of asymptomatic bacteriuria (ASB). The Infectious Diseases Society of America recommends against antibiotic treatment of ASB for most patients including those presenting with altered mental status (AMS). Close observation is recommended over treatment to avoid missing alternative causes of AMS and overuse of antibiotics resulting in adverse events
-
Collaborative drug therapy modification (CDTM): Facilitators, barriers, and perceptions of individual pharmacist participation in Georgia J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-16 Sharmon P. Osae, Russ Palmer, Ashlee Harvey, Chelsea A. Keedy, Devin L. Lavender, Beth Bryles Phillips, Blake R. Johnson, Henry N. Young, Rebecca H. Stone
Georgia Board of Pharmacy (BOP) regulations permit pharmacists to engage in collaborative drug therapy modification (CDTM) with physicians, allowing them to perform patient assessments, adjust pharmacotherapy, and order laboratory tests. Pharmacist-led CDTM can positively affect health outcomes leading to reduced healthcare expenditures. CDTM is underutilized, with < 1% of Georgia pharmacists holding
-
Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-15 Alexis C. Jones, Frank Tillman III, Christie Kahlon, Randy Seys, Marc Pepin
There is currently a clinical dilemma in treating acute pain in patients receiving long-term buprenorphine products. This is a retrospective cohort review involving patients receiving long-term buprenorphine therapy who either underwent a surgical procedure or presented to an emergency department (ED) for acute pain between January 1, 2012 and January 1, 2022. Patients were excluded if opioids were
-
Acyclovir dosing in herpes encephalitis: A scoping review J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-15 Asma Aboelezz, Sherif Hanafy Mahmoud
Herpes encephalitis, a rare yet potentially fatal viral infection, is treated exclusively with acyclovir, the sole antiviral medication used for this condition. Acyclovir recommended dose is 10 mg/kg/dose intravenous every 8 hours; however, it is unclear what body weight should be utilized in obese patients. Using the ideal body weight may result in subtherapeutic ineffective concentrations, while
-
Despair and Hope: Is the retail community pharmacy workforce in danger of becoming a monopsony labor market? J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-14 Mark Bounthavong
Mergers of big chain retail community pharmacies can impact the competitiveness of the pharmacy workforce to negotiate better wages and work conditions. However, it is unclear whether these types of mergers are generalizable to the US pharmacy workforce. We should observe this effect when comparing annual wage trends between retail community pharmacy workers to non-retail community pharmacy workers
-
Ohio pharmacy personnel’s burnout and wellbeing: The impact of the COVID-19 pandemic J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-14 Rebecca J. McCloskey, Robert Santucci, Gretchen C. Hammond
While burnout is a well-known phenomenon among physicians and nurses, burnout among pharmacists and pharmacy personnel is understudied and less recognized. The primary objectives of this study were to describe and compare Ohio pharmacy personnel’s self-reports of burnout and wellbeing prior to and during the COVID-19 pandemic. A one-time online survey was completed by over 13,000 health care professionals
-
How to Implement a “Standard of Care” Regulatory Model for Pharmacists J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-12 Alex J. Adams, Nicole L. Chopski, Jennifer Athay Adams
-
Effects of instructional video and community radio broadcasting interventions to improve knowledge and behavior of antibiotic use in the COVID-19 era J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-09 Natthaya Chaomuang, Rujira Panya, Surasak Saokaew, Adinat Umnuaypornlert
Antibiotic overuse is a serious health issue. It has been demonstrated that improper antibiotic use is linked to a lack of knowledge in the public. To encourage judicious antibiotic use in the COVID-19 ERA, it is critical to provide accessible and secure therapies. This study aimed to assess the effects of instructional video and community radio broadcasting interventions on knowledge and behavior
-
Implementation of Depression Management by Ambulatory Care Pharmacists in the Primary Care Setting J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-08 Katherine F. Brown, Katherine A. Curtis, Megan M. Kline, Rachael A. Hiday
In the United States, depression is one of the most common mental health disorders. Ambulatory care pharmacists play a critical role in assisting with medication and dosage selection, identifying and managing drug interactions and adverse effects, and increasing medication adherence. Existing data on depression management by ambulatory care pharmacists trained in primary care is limited and outdated
-
Quantitative and qualitative survey feedback of pharmacists regarding current and prospective licensure models. J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-08 Jessie Parker, Rebecca Howard, Andrew Holick, Erin Johanson
Despite variation in licensure requirements and models for pharmacy practice nationwide, there is little published data within the United States regarding pharmacist perspectives. The purpose of this study was to identify the demographics, awareness, and perceptions about current pharmacist licensure models. A fifteen-question mixed-methods survey was created and distributed via Qualtrics-XM Survey
-
Determining the Association Between Grocery Nutrition Scores and Number of Medications Taken for Metabolic Syndrome: A Pilot Study J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-08 Alexandra Q. Dawson, Andrew G. Azzi, Scott M. Schimmel, Mitchell S. Howard
Metabolic syndrome is a cluster of disease states that increases an individual’s risk of developing diabetes or cardiovascular disease. When treating metabolic syndrome, lifestyle and diet are primary areas for interventions. A dietician-led grocery nutrition system scoring patient’s purchases may correlate to better control of metabolic health. To compare the number of medications taken for metabolic
-
Patient activation and medication adherence in adults J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-04 Joshua Caballero, Neil Patel, Drenna Waldrop, Raymond L. Ownby
Patients’ level of medication adherence provides conflicting results in its relationship to patient activation. Multiple factors may be contributing to these mixed results. The primary purpose was to assess the association of patient activation to medication adherence in adults with chronic health conditions and low health literacy. Secondary objectives were to determine if age, education, gender,
-
Naloxone access in perinatal substance use disorder J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-04 Abigail C. Bechtol, Melinda Ramage, Linas J. Krulikas, Kylie Futrell, Olivia Caron
Risk of fatal drug overdose is higher in pregnant and postpartum people with substance use disorder (SUD) than for nonpregnant women of reproductive age. It is recommended that naloxone is prescribed for pregnancies complicated by opioid or stimulant use disorder. The purpose of this study was to assess the rates of naloxone coprescribing with buprenorphine in a perinatal SUD (PSUD) specialty clinic
-
Actions speak louder than words: Taking a stand for reproductive health care and gender-affirming care J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Jordan R. Covvey, Jeffrey P. Bratberg
-
Evaluation of pharmacist-led transition of care program in patients with acute coronary syndrome J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Jove Graham, Stephen J. Voyce, Jessica R. Hayden, Aanya Chopra, Jason Tinsley, Natasha Singh, Amir Eslami, Stacey Grassi, Adriene Zook, Bradley Lauver, Samuel Eckel, Vanessa A. Hayduk, Melissa S. Kern, Shikhar Agarwal, Eric A. Wright
Guideline-directed medical therapies (GDMT), initiated in-hospital and continued during the transition to outpatient care, are paramount to successful outcomes for patients with acute coronary syndrome (ACS). Incomplete discharge medication prescribing and delayed follow up lead to worse cardiovascular outcomes. We investigated a system of care using inpatient and outpatient clinical pharmacists to
-
Revolutionizing pharmacy practice in 2037 J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Samm Anderegg
Abstract not available
-
Transformative education: Nurturing AI proficiency in pharmacy J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Shefa Ali
Abstract not available
-
Parents’ perspectives on using a Family Medication Safety Plan designed to promote appropriate opioid prescription practices with adolescents J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Olufunmilola Abraham, Grace C. Klubertanz, Ellie N. Maday
Research has underscored the vulnerability of adolescents to opioid misuse, creating a call-to-action for researchers and practitioners to identify ways to reduce the youths’ risk of opioid misuse. While strategies have previously been proposed, few studies have targeted and designed interventions for adolescents and their families. The Family Medication Safety Plan (FMSP) was developed to provide
-
-
Partnering to advance pharmacy J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Pamela C. Heaton
Abstract not available
-
Role of artificial intelligence in pharmaceutical health care J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Z. Kevin Lu
Abstract not available
-
Network meta-analysis of MS DMTs: In response to “Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis” by Chen et al. J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Khalil Jomaa, Mattia Gianinazzi, Angela Guerra, Changyu Shen, Thomas Debray
Abstract not available
-
Reply: Network meta-analysis of MS DMTs J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-02 Chaoyang Chen, Enyao Zhang, Chunsu Zhu, Ran Wei, Lingyun Ma, Xiu Dong, Ruoming Li, Feng Sun, Ying Zhou, Yimin Cui, Zhenming Liu
Abstract not available
-
Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-01 Grace Marley, Izabela E. Annis, Bayla Ostrach, Kathleen Egan, Paul L. Delamater, Ronny Bell, Nabarun Dasgupta, Delesha M. Carpenter
According to a standing order in North Carolina (NC), naloxone can be purchased without a provider prescription. The objective of this study is to examine whether same-day naloxone accessibility and cost vary by pharmacy type and rurality in NC. A cross-sectional telephone audit of 202 NC community pharmacies stratified by pharmacy type and county of origin was conducted in March and April 2023. Trained
-
Association between antibiotic administration before discharge and emergency department length of stay for urinary tract infection: A retrospective analysis J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-02-01 Mohammed A. Alrashed, Stephen J. Perona, Mark C. Borgstrom, Elias Ramirez-Moreno
Patients with urinary tract infections (UTIs) may have treatment initiated in the emergency department (ED) before discharge with an antibiotic prescription. The effect of a single antibiotic dose administered before discharge on ED length of stay (LOS) is unknown. The purpose of this study was to compare the LOS and the rate of revisits within 30 days among patients diagnosed as having UTIs other
-
From outcomes to elections: How elected pharmacists are key to the improvement of our community and profession J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-26 Dr. Oye Owolewa
Abstract not available
-
Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement. J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-23 Joseph Korzec, Ryan Strausbaugh, Jeffrey J. Mikolay, Mariann D. Churchwell
Abstract not available
-
Addressing buprenorphine supply barriers: A guidance commentary J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-23 Jordan W. Khail, Smita Rawal, Henry N. Young, Joshua Caballero
The current supply-side constraints limiting buprenorphine availability at pharmacies may reduce the potential impact of recent initiatives to improve Medications for Opioid Use Disorder (MOUD) access. The recent opioid litigation combined with existing federal regulation and enforcement has resulted in significant restrictions to the distribution and dispensing practices of pharmaceutical wholesalers
-
Exploring LGBTQ+ cultural competency and DEI in continuing education: A cross-sectional review of U.S. pharmacy legislation J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-23 Jennifer Ko, Jeremy Carlos, Yvonne Nguyen
Lesbian, gay, bisexual, transgender, queer or questioning, intersex, asexual, or other sexual orientations or gender identities (LGBTQ+) cultural competency training is offered in pharmacy curricula to variable extents. State legislation directly dictates pharmacist training through continuing pharmacy education (CPE) requirements. This study aimed to identify the U.S. states and the District of Columbia
-
Benefit of clinical pharmacists in neurology clinics at an academic medical center J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-19 Bethany Anderson, Melissa J. Snider, Margaret Hansen, Caitlin Parks, Aaron Bagnola, Junan Li, Miriam Freimer, Benjamin Segal
Patients with neurologic diseases have complex medical needs and may benefit from the addition of clinical pharmacists in their care. This study aimed to describe integration and benefit of clinical pharmacists in neuroimmunology and neuromuscular clinics at an academic medical center. This retrospective chart review evaluated patients initiated on a neurology medication for a neuroimmunology or neuromuscular
-
Transitioning to virtual academic detailing amid COVID-19: A case study J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-19 Paula Cameron, Kelly MacKinnon, Anne Mahalik
Coronavirus disease 2019 (COVID-19) public health protocols required medical educators to rapidly move curricula online. This included academic detailing (AD), a form of one-to-one or small group educational outreach for primary care providers (PCPs). This study aimed to contribute to the sparse evidence base exploring virtual AD by exploring strengths, challenges, and best practices. This case study
-
Reconsidering the residency training pathway for ambulatory care pharmacists J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-19 Jean Y. Moon, Sarah M. Westberg, Todd D. Sorensen
Ambulatory care, commonly found in primary care settings, is a growing area of pharmacy practice supported by an expanding number of residency training opportunities in this setting. As this practice expands, the profession has chosen to adopt structures that define it as a specialty practice area, a departure from the medical profession. A key example of this definition is the profession’s alignment
-
Implementation of pharmacy-led preoperative medication reconciliation in surgical oncology patients J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-11 Taylor M. Bormann, Kristin I. Brower, Charlotte M. Forshay
Pharmacy-led medication history collection and reconciliation have demonstrated decreased medication errors, increased patient safety, and improved cost-savings. However, literature lacks documented efforts to implement such services in the preoperative space, where having accurate medication lists following complex procedures with high postoperative admission rates is critical. The purpose of this
-
Access to community pharmacies based on drive time and by rurality across the contiguous United States J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-11 Nasser Sharareh, Alexander R. Zheutlin, Dima M. Qato, Jenny Guadamuz, Adam Bress, Robert O. Vos
Considering that mail-order pharmacy use remains low in the United States, geographic accessibility of community pharmacies (pharmacy access) can have an outsized impact on a community’s access to services and care, especially among rural residents. However, previous measurements of pharmacy access rely on methods that do not capture all aspects of geographic access. This study aimed to measure pharmacy
-
Using insulin pump for glycemic control in patients with severe insulin resistance J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-11 Maria Procaccini, Anthony Garrett Allegra, Dana Burns, Evan Sisson
Patients with type 2 diabetes using a continuous subcutaneous insulin infusion (CSII) often require large doses of insulin and need to change their insulin administration sets frequently. A proposed solution to this problem is to use concentrated insulin in their insulin pump; however, insulin pumps are programmed to administer U-100 insulin. Therefore, these patients are at greater risk of hypoglycemia
-
Prevention of iatrogenic fluid overload with naloxone infusions: A patient safety initiative J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-10 Christopher L. Kennedy, Laura N. Hayn, Natalie E. Ebeling-Koning, Gillian A. Beauchamp
A higher number of patients admitted to hospital systems are requiring a naloxone infusion for treatment of opioid toxicity. While naloxone is a safe antidote for the treatment of opioid toxicity, this is not without the risk of iatrogenic harm. During standard pharmacy medication safety review process, it was identified that our standard naloxone concentration protocol would deliver four-times the
-
Impact of an HIV pre-exposure prophylaxis dashboard on veteran PrEP enrollment J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-10 Mary Kate Kerbler, Carrie Isaacs, Courtney Eatmon, Jennifer Reid, Kelly W. Davis
Pre-exposure prophylaxis (PrEP) is highly effective at reducing the risk of human immunodeficiency virus (HIV) acquisition in at-risk individuals; however, it is largely underutilized. The Veterans Health Administration has created an HIV PrEP dashboard to identify at-risk veterans in attempt to increase PrEP enrollment. This study aimed to determine whether the use of an HIV PrEP dashboard would prove
-
IDS pharmacists: Bridging the translational research gap for pharmacy practice J. Am. Pharm. Assoc. (IF 2.1) Pub Date : 2024-01-06 Jill E. Blind, Julie Leary
Abstract not available